Related Experiment Video
Updated: May 26, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
[Significance of MUM-1/IRF4 protein expression in follicular lymphoma]
Ying-ying Huo1, Yi Pan, Bing-xin Guan
1Department of Pathology, Shandong University School of Medicine, Jinan, China.
Insights
MUM-1/IRF4 protein expression is significantly elevated in high-grade follicular lymphoma, correlating with increased proliferation and aggressive behavior. This marker aids in diagnosing high-grade follicular lymphoma.
Area of Science:
- Oncology
- Hematopathology
- Molecular Diagnostics
Background:
- Follicular lymphoma (FL) is a common indolent non-Hodgkin lymphoma.
- Accurate grading and prognostic assessment are crucial for treatment decisions.
- The role of MUM-1/IRF4 in FL progression requires further elucidation.
Purpose of the Study:
- To investigate the expression patterns of MUM-1/IRF4 in follicular lymphoma.
- To determine the significance of MUM-1/IRF4 expression in relation to FL grade and other markers.
Main Methods:
- Ninety-eight follicular lymphoma cases were analyzed using tissue microarray and immunohistochemistry.
- Cases were graded according to 2008 WHO criteria.
- Expression of MUM-1/IRF4, CD10, bcl-6, bcl-2, and Ki-67 was assessed.
Main Results:
- MUM-1/IRF4 was expressed in 39.8% of cases, predominantly in high-grade FL (grades 3A and 3B).
- MUM-1/IRF4 expression showed a significant positive correlation with FL grade and Ki-67 index.
- Negative correlation was observed between MUM-1/IRF4 and CD10 expression.
Conclusions:
- Elevated MUM-1/IRF4 expression is associated with high-grade follicular lymphoma.
- High MUM-1/IRF4 expression indicates increased proliferative activity, aggressive behavior, and poorer prognosis.
- MUM-1/IRF4 serves as a valuable diagnostic marker for high-grade FL.
Objective:
To study the expression of MUM-1/IRF4 and its significance in follicular lymphoma.
Methods:
Ninety-eight cases of follicular lymphoma were enrolled into the study. They were graded according to the 2008 WHO criteria. The expression of MUM-1/IRF4 protein and other markers (CD10, bcl-6, bcl-2 and Ki-67) was studied using tissue microarray and immunohistochemistry.
Results:
Amongst the 98 cases studied, there were 24 grade 1 cases, 30 grade 2 cases, 26 grade 3A cases and 18 were grade 3B cases. The rates of expression of MUM-1/IRF4, CD10, bcl-6, bcl-2 and Ki-67 (≥ 25%) were 39.8% (39/98), 62.2% (61/98), 80.6% (79/98), 87.8% (86/98) and 50.0% (49/98), respectively. MUM-1/IRF4 predominantly expressed in high-grade follicular lymphoma and showed a significantly positive correlation with lymphoma grade (r = 0.628, P = 0.000) and Ki-67 index (r = 0.473, P = 0.000). MUM-1/IRF4 expression had a significantly negative correlation with CD10 expression (r = -0.597, P = 0.000), but no correlation with bcl-6 and bcl-2 expression.
Conclusions:
MUM-1/IRF4 expression is significantly higher in high-grade follicular lymphoma, indicating that these cases have a high proliferative activity, more aggressive behavior and poorer prognosis. MUM-1/IRF4, when strongly expressed, is another helpful marker for the diagnosis of high-grade follicular lymphoma.
Related Concept Videos
Abnormal Proliferation
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
